Drug Related Problems (DRPs) Analysis Of An Obesity Patient Who Received Antihypertension And Oral Antidiabetic Drugs

Analisis Drug Related Problems (DRPs) Seorang Pasien Obesitas Yang Menggunakan Obat Antihipertensi Dan Antidiabetik Oral

Authors

  • Niken Indriyanti KBI Farmakologi, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
  • Theresia Fenny Oktarina Program Studi Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
  • Andi Atirah Melinda Septiani Program Studi Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
  • Nila Shafira Sukmawati Program Studi Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
  • Winchy Putri Cantika Program Studi Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
  • Erin Febi Meliana Pasaribu Program Studi Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
  • Melynda Rahma Program Studi Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
  • Muhammad Abil Arqam Program Studi Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
  • Aulia Safitri Program Studi Sarjana Farmasi Klinis, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
  • Rezky Nur Ardyah Program Studi D III Farmasi, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia

DOI:

https://doi.org/10.53342/pharmasci.vi.399

Keywords:

Diabetes Melitus, DRPs, Amlodipine, Simvastatin

Abstract

Metabolic disorder needs lifelong treatment, in order to increase their quality of life. Medication adherence and healthy lifestyle is a key to stabilize patient’s condition. This research is a case report of an obesity woman aged 50 yo who received amlodipine, simvastatin, dan metformin. Patient had embolic stroke 13 years ago. Patient’s blood pressure is 144/81 mmHg, fasting blood glucose level is 211 mg/dL, cholesterol level is 279 mg/dL, body weight 59 kg, 150 cm tall. Nutritional status of this patient is obesity level 1 due to BMI 26,2. DRP analysis was performed by using literature review. Some DRPs occur, but it can be solved by educating patient. Some dose arrangements can be useful for this patient.

Downloads

Published

2024-06-17

How to Cite

Drug Related Problems (DRPs) Analysis Of An Obesity Patient Who Received Antihypertension And Oral Antidiabetic Drugs : Analisis Drug Related Problems (DRPs) Seorang Pasien Obesitas Yang Menggunakan Obat Antihipertensi Dan Antidiabetik Oral. (2024). Journal Pharmasci (Journal of Pharmacy and Science), 43-48. https://doi.org/10.53342/pharmasci.vi.399